Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma

BACKGROUND: Dysregulated oncomiRs are attributed to hepatocellular carcinoma (HCC) through targeting mTOR signaling pathway responsible for cell growth and proliferation. The potential of these oncomiRs as biomarker for tumor response or as target for therapy needs to be evaluated. AIM: Tumor respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadda, Neeti, Paul, Shashi Bala, Yadav, Dawesh P., Kumar, Sonu, Sreenivas, Vishnubhatla, Saraya, Anoop, Gamanagatti, Shivanand, Acharya, Subrat Kumar, Shalimar, Nayak, Baibaswata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890014/
https://www.ncbi.nlm.nih.gov/pubmed/33614488
http://dx.doi.org/10.3389/fonc.2020.604540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890014/
https://www.ncbi.nlm.nih.gov/pubmed/33614488
http://dx.doi.org/10.3389/fonc.2020.604540

Ejemplares similares